Wyeth's Alzheimer's Vaccine Could Become World's #1 Drug - Barron's [View article]
cack211 -- very sorry about your loss. I indeed hope this, or something like it, is the breakthrough that so many are waiting for.
Having said that, I don't think discussions of the therapeutic and commercial benefits of new medicines are mutually exclusive. If all the medicines waiting to be discovered were to have to wait for massive charitable donations alone before they were discovered, I daresay the wait would be a whole lot longer. The fact commercial interests can make big money from breakthrough medicines is no doubt an impetus for their discovery and development, and as such I think the discussion thereof is healthy and should be facilitated.
Wyeth's Alzheimer's Vaccine Could Become World's #1 Drug - Barron's [View article]
AZErnie: To be fair, Barron's does mention Elan (ELN) in passing. Here's the quote:
"For New Jersey-based Wyeth (ticker: WYE) and its Irish partner, Elan (ELN), the companies sponsoring the research, it would hold out the prospect of a drug with exceptional promise. And for Wyeth, in particular -- whose shares have languished for a decade and been pummeled of late -- it could ultimately mean investment redemption."
Wyeth's Alzheimer's Vaccine Could Become World's #1 Drug - Barron's [View article]
Having said that, I don't think discussions of the therapeutic and commercial benefits of new medicines are mutually exclusive. If all the medicines waiting to be discovered were to have to wait for massive charitable donations alone before they were discovered, I daresay the wait would be a whole lot longer. The fact commercial interests can make big money from breakthrough medicines is no doubt an impetus for their discovery and development, and as such I think the discussion thereof is healthy and should be facilitated.
Wyeth's Alzheimer's Vaccine Could Become World's #1 Drug - Barron's [View article]
"For New Jersey-based Wyeth (ticker: WYE) and its Irish partner, Elan (ELN), the companies sponsoring the research, it would hold out the prospect of a drug with exceptional promise. And for Wyeth, in particular -- whose shares have languished for a decade and been pummeled of late -- it could ultimately mean investment redemption."